Correlation Between AptaBio Therapeutics and INtRON Biotechnology
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and INtRON Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and INtRON Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and iNtRON Biotechnology, you can compare the effects of market volatilities on AptaBio Therapeutics and INtRON Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of INtRON Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and INtRON Biotechnology.
Diversification Opportunities for AptaBio Therapeutics and INtRON Biotechnology
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between AptaBio and INtRON is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and iNtRON Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iNtRON Biotechnology and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with INtRON Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iNtRON Biotechnology has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and INtRON Biotechnology go up and down completely randomly.
Pair Corralation between AptaBio Therapeutics and INtRON Biotechnology
Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the INtRON Biotechnology. In addition to that, AptaBio Therapeutics is 1.4 times more volatile than iNtRON Biotechnology. It trades about -0.27 of its total potential returns per unit of risk. iNtRON Biotechnology is currently generating about -0.11 per unit of volatility. If you would invest 575,000 in iNtRON Biotechnology on September 2, 2024 and sell it today you would lose (31,000) from holding iNtRON Biotechnology or give up 5.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AptaBio Therapeutics vs. iNtRON Biotechnology
Performance |
| Timeline |
| AptaBio Therapeutics |
| iNtRON Biotechnology |
AptaBio Therapeutics and INtRON Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AptaBio Therapeutics and INtRON Biotechnology
The main advantage of trading using opposite AptaBio Therapeutics and INtRON Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, INtRON Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INtRON Biotechnology will offset losses from the drop in INtRON Biotechnology's long position.| AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
| INtRON Biotechnology vs. AptaBio Therapeutics | INtRON Biotechnology vs. KT Hitel | INtRON Biotechnology vs. SillaJen | INtRON Biotechnology vs. Cytogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |